327 related articles for article (PubMed ID: 24565907)
1. The potential of heparanase as a therapeutic target in cancer.
Pisano C; Vlodavsky I; Ilan N; Zunino F
Biochem Pharmacol; 2014 May; 89(1):12-9. PubMed ID: 24565907
[TBL] [Abstract][Full Text] [Related]
2. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
[TBL] [Abstract][Full Text] [Related]
3. Role of heparanase in tumor progression: Molecular aspects and therapeutic options.
Masola V; Zaza G; Gambaro G; Franchi M; Onisto M
Semin Cancer Biol; 2020 May; 62():86-98. PubMed ID: 31348993
[TBL] [Abstract][Full Text] [Related]
4. Heparanase involvement in physiology and disease.
Nasser NJ
Cell Mol Life Sci; 2008 Jun; 65(11):1706-15. PubMed ID: 18425416
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory Activities of the Heparan Sulfate Mimetic PG545.
Bendersky V; Yang Y; Brennan TV
Adv Exp Med Biol; 2020; 1221():461-470. PubMed ID: 32274722
[TBL] [Abstract][Full Text] [Related]
6. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.
Barash U; Cohen-Kaplan V; Dowek I; Sanderson RD; Ilan N; Vlodavsky I
FEBS J; 2010 Oct; 277(19):3890-903. PubMed ID: 20840586
[TBL] [Abstract][Full Text] [Related]
7. Development of heparanase inhibitors for anti-cancer therapy.
Miao HQ; Liu H; Navarro E; Kussie P; Zhu Z
Curr Med Chem; 2006; 13(18):2101-11. PubMed ID: 16918340
[TBL] [Abstract][Full Text] [Related]
8. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.
Vlodavsky I; Ilan N; Naggi A; Casu B
Curr Pharm Des; 2007; 13(20):2057-73. PubMed ID: 17627539
[TBL] [Abstract][Full Text] [Related]
9. The Good and Bad Sides of Heparanase-1 and Heparanase-2.
Pinhal MAS; Melo CM; Nader HB
Adv Exp Med Biol; 2020; 1221():821-845. PubMed ID: 32274740
[TBL] [Abstract][Full Text] [Related]
10. Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases.
Rivara S; Milazzo FM; Giannini G
Future Med Chem; 2016 Apr; 8(6):647-80. PubMed ID: 27057774
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of heparanase inhibitors in cancer therapy.
Heyman B; Yang Y
Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.
Jia L; Ma S
Eur J Med Chem; 2016 Oct; 121():209-220. PubMed ID: 27240275
[TBL] [Abstract][Full Text] [Related]
13. Heparanase and cancer progression: New directions, new promises.
Arvatz G; Weissmann M; Ilan N; Vlodavsky I
Hum Vaccin Immunother; 2016 Sep; 12(9):2253-6. PubMed ID: 27054564
[TBL] [Abstract][Full Text] [Related]
14. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development.
Vlodavsky I; Goldshmidt O; Zcharia E; Atzmon R; Rangini-Guatta Z; Elkin M; Peretz T; Friedmann Y
Semin Cancer Biol; 2002 Apr; 12(2):121-9. PubMed ID: 12027584
[TBL] [Abstract][Full Text] [Related]
15. Impact of heparanase and the tumor microenvironment on cancer metastasis and angiogenesis: basic aspects and clinical applications.
Vlodavsky I; Elkin M; Ilan N
Rambam Maimonides Med J; 2011 Jan; 2(1):e0019. PubMed ID: 23908791
[TBL] [Abstract][Full Text] [Related]
16. Heparanase: Historical Aspects and Future Perspectives.
Khanna M; Parish CR
Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
[TBL] [Abstract][Full Text] [Related]
18. Heparanase in inflammation and inflammation-associated cancer.
Meirovitz A; Goldberg R; Binder A; Rubinstein AM; Hermano E; Elkin M
FEBS J; 2013 May; 280(10):2307-19. PubMed ID: 23398975
[TBL] [Abstract][Full Text] [Related]
19. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
20. The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.
Ramani VC; Purushothaman A; Stewart MD; Thompson CA; Vlodavsky I; Au JL; Sanderson RD
FEBS J; 2013 May; 280(10):2294-306. PubMed ID: 23374281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]